Parametric Portfolio Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$1.13M Buy
40,228
+5,464
+16% +$154K ﹤0.01% 2724
2021
Q4
$1.6M Buy
34,764
+9,398
+37% +$433K ﹤0.01% 2575
2021
Q3
$833K Sell
25,366
-3,543
-12% -$116K ﹤0.01% 2882
2021
Q2
$1.01M Buy
28,909
+9,924
+52% +$348K ﹤0.01% 2764
2021
Q1
$686K Buy
18,985
+1,064
+6% +$38.4K ﹤0.01% 3337
2020
Q4
$520K Sell
17,921
-17,684
-50% -$513K ﹤0.01% 3364
2020
Q3
$1M Buy
35,605
+3,474
+11% +$98K ﹤0.01% 2917
2020
Q2
$1.04M Buy
32,131
+14,657
+84% +$474K ﹤0.01% 2904
2020
Q1
$712K Sell
17,474
-8,605
-33% -$351K ﹤0.01% 2978
2019
Q4
$1.61M Sell
26,079
-4,185
-14% -$258K ﹤0.01% 2827
2019
Q3
$2.21M Sell
30,264
-1,793
-6% -$131K ﹤0.01% 2577
2019
Q2
$2.64M Buy
32,057
+6,802
+27% +$559K ﹤0.01% 2479
2019
Q1
$1.78M Buy
25,255
+2,070
+9% +$146K ﹤0.01% 2721
2018
Q4
$1.04M Buy
23,185
+2,541
+12% +$114K ﹤0.01% 2959
2018
Q3
$1.17M Sell
20,644
-992
-5% -$56.1K ﹤0.01% 3005
2018
Q2
$1.45M Buy
21,636
+1,948
+10% +$130K ﹤0.01% 2862
2018
Q1
$1.15M Buy
19,688
+4,328
+28% +$252K ﹤0.01% 2944
2017
Q4
$990K Sell
15,360
-408
-3% -$26.3K ﹤0.01% 3024
2017
Q3
$828K Buy
15,768
+798
+5% +$41.9K ﹤0.01% 3143
2017
Q2
$701K Buy
14,970
+3,133
+26% +$147K ﹤0.01% 3176
2017
Q1
$586K Sell
11,837
-829
-7% -$41K ﹤0.01% 3119
2016
Q4
$768K Buy
12,666
+1,010
+9% +$61.2K ﹤0.01% 2976
2016
Q3
$773K Buy
11,656
+3,240
+38% +$215K ﹤0.01% 2948
2016
Q2
$470K Buy
8,416
+291
+4% +$16.3K ﹤0.01% 3230
2016
Q1
$273K Buy
+8,125
New +$273K ﹤0.01% 3637
2015
Q3
Sell
-7,113
Closed -$441K 3265
2015
Q2
$441K Sell
7,113
-8,972
-56% -$556K ﹤0.01% 3351
2015
Q1
$1.01M Sell
16,085
-1,880
-10% -$118K ﹤0.01% 2782
2014
Q4
$1.01M Buy
17,965
+4,050
+29% +$228K ﹤0.01% 2776
2014
Q3
$394K Buy
13,915
+1,687
+14% +$47.8K ﹤0.01% 3343
2014
Q2
$421K Buy
12,228
+441
+4% +$15.2K ﹤0.01% 3310
2014
Q1
$370K Buy
+11,787
New +$370K ﹤0.01% 3341